TR200402454T4 - C-4 karbonat taksanlar. - Google Patents

C-4 karbonat taksanlar.

Info

Publication number
TR200402454T4
TR200402454T4 TR2004/02454T TR200402454T TR200402454T4 TR 200402454 T4 TR200402454 T4 TR 200402454T4 TR 2004/02454 T TR2004/02454 T TR 2004/02454T TR 200402454 T TR200402454 T TR 200402454T TR 200402454 T4 TR200402454 T4 TR 200402454T4
Authority
TR
Turkey
Prior art keywords
formula
compounds
taxanes
carbonate
zopropyl
Prior art date
Application number
TR2004/02454T
Other languages
English (en)
Turkish (tr)
Inventor
F. Kadow John
Mastalerz Harold
May Xue Qiufen
Hansel Steven
Edson Zoeckler Mary
C. Rose William
G. Tarrant James
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of TR200402454T4 publication Critical patent/TR200402454T4/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Carbon And Carbon Compounds (AREA)
TR2004/02454T 2000-02-03 2000-11-16 C-4 karbonat taksanlar. TR200402454T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17996500P 2000-02-03 2000-02-03

Publications (1)

Publication Number Publication Date
TR200402454T4 true TR200402454T4 (tr) 2004-12-21

Family

ID=22658728

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02454T TR200402454T4 (tr) 2000-02-03 2000-11-16 C-4 karbonat taksanlar.

Country Status (20)

Country Link
US (1) US6750246B1 (cg-RX-API-DMAC7.html)
EP (1) EP1251846B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003523971A (cg-RX-API-DMAC7.html)
AT (1) ATE273005T1 (cg-RX-API-DMAC7.html)
AU (1) AU778284B2 (cg-RX-API-DMAC7.html)
CA (1) CA2399116A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20022956A3 (cg-RX-API-DMAC7.html)
DE (1) DE60012988T2 (cg-RX-API-DMAC7.html)
DK (1) DK1251846T3 (cg-RX-API-DMAC7.html)
ES (1) ES2226954T3 (cg-RX-API-DMAC7.html)
HK (1) HK1047891B (cg-RX-API-DMAC7.html)
MY (1) MY129310A (cg-RX-API-DMAC7.html)
NZ (1) NZ521136A (cg-RX-API-DMAC7.html)
PE (1) PE20020747A1 (cg-RX-API-DMAC7.html)
PT (1) PT1251846E (cg-RX-API-DMAC7.html)
RU (1) RU2243223C2 (cg-RX-API-DMAC7.html)
TR (1) TR200402454T4 (cg-RX-API-DMAC7.html)
TW (2) TWI245041B (cg-RX-API-DMAC7.html)
WO (1) WO2001056565A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200207037B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6916942B2 (en) * 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
EP1623706A3 (en) * 2001-02-28 2006-02-22 Bristol-Myers Squibb Company Metronomic dosing of taxanes for inhibiting tumor growth
UY27185A1 (es) * 2001-02-28 2002-09-30 Bristol Myers Squibb Co Dosificación metronómica de taxanos
US7063977B2 (en) * 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
RS52904A (sr) * 2001-12-20 2006-12-15 Bristol-Myers Squib Company Farmaceutske smeše oralno aktivnih derivata taksana koje imaju povećanu bioraspoloživost
US20070105944A1 (en) * 2002-10-25 2007-05-10 Comezoglu S N Taxane metabolites
US7371759B2 (en) * 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
TW200533339A (en) * 2004-03-16 2005-10-16 Bristol Myers Squibb Co Therapeutic synergy of anti-cancer compounds
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
TW200538453A (en) * 2004-04-26 2005-12-01 Bristol Myers Squibb Co Bicyclic heterocycles as kinase inhibitors
US7173031B2 (en) 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7439246B2 (en) * 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
US20060116420A1 (en) * 2004-11-23 2006-06-01 Ramakrishnan Chidambaram Crystalline forms of 3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxycarbonyl-paclitaxel
US20060258736A1 (en) * 2005-05-12 2006-11-16 Bristol-Myers Squibb Company Dosing regimen
US20080221135A1 (en) * 2005-05-13 2008-09-11 Bristol-Myers Squibb Company Combination therapy
US7348325B2 (en) 2005-11-30 2008-03-25 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
PL217731B1 (pl) 2006-06-01 2014-08-29 Tomasz Byrski Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi
HRP20171537T1 (hr) 2009-11-05 2017-12-15 Rhizen Pharmaceuticals S.A. Novi modulatori benzopiran kinaze

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110249A (en) 1989-05-31 1998-03-31 Univ Florida State Method for preparation of taxol using beta lactam
US6335362B1 (en) 1991-09-23 2002-01-01 Florida State University Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
US6521660B2 (en) 1991-09-23 2003-02-18 Florida State University 3′-alkyl substituted taxanes and pharmaceutical compositions containing them
US5399726A (en) 1993-01-29 1995-03-21 Florida State University Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US5284865A (en) 1991-09-23 1994-02-08 Holton Robert A Cyclohexyl substituted taxanes and pharmaceutical compositions containing them
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
FR2698871B1 (fr) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
KR100356448B1 (ko) 1992-12-23 2002-10-19 브리스톨-마이어스스퀴브컴파니 신규 측쇄-함유 탁산 및 그의 중간체 화합물
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5567592A (en) 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
FR2721024B1 (fr) * 1994-06-09 1996-07-12 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5767296A (en) 1994-06-09 1998-06-16 Daiichi Pharmaceutical Co., Ltd. Deacetoxytaxol derivatives
FR2726272B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US5840929A (en) 1995-04-14 1998-11-24 Bristol-Myers Squibb Company C4 methoxy ether derivatives of paclitaxel
TW354293B (en) 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US6964946B1 (en) 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
US5739359A (en) * 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
AU759030B2 (en) 1997-12-31 2003-04-03 Bristol-Myers Squibb Company 2-aroyl-4-acyl paclitaxel (taxol) analogs
DE60007115T2 (de) 1999-05-17 2004-09-02 Bristol-Myers Squibb Co. Neue Umsetzungsbedingungen für die Spaltung von Silylethern bei der Herstellung von Paclitaxel (Taxol) und Paclitaxelanaloga
ES2219372T3 (es) 1999-08-11 2004-12-01 Bristol-Myers Squibb Company Procedimiento para preparar un analogo carbonato de metilo c-4 de paclitaxel.
CN1450923A (zh) 1999-10-27 2003-10-22 巴克·诺顿药物有限公司 给病人口服给予紫杉烷的方法和组合物
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
JP2004520398A (ja) 2001-01-18 2004-07-08 ファルマシア・アンド・アップジョン・カンパニー 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物
UY27185A1 (es) 2001-02-28 2002-09-30 Bristol Myers Squibb Co Dosificación metronómica de taxanos
DE10154464B4 (de) 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
WO2003045357A1 (en) 2001-11-27 2003-06-05 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof

Also Published As

Publication number Publication date
CZ20022956A3 (cs) 2003-02-12
AU1769201A (en) 2001-08-14
MY129310A (en) 2007-03-30
TWI245042B (en) 2005-12-11
PT1251846E (pt) 2004-11-30
HK1047891A1 (en) 2003-03-14
EP1251846A4 (en) 2003-03-12
JP2003523971A (ja) 2003-08-12
TW200526613A (en) 2005-08-16
AU778284B2 (en) 2004-11-25
DE60012988D1 (en) 2004-09-16
RU2002123641A (ru) 2004-01-10
EP1251846B1 (en) 2004-08-11
ES2226954T3 (es) 2005-04-01
ATE273005T1 (de) 2004-08-15
ZA200207037B (en) 2003-12-02
WO2001056565A1 (en) 2001-08-09
RU2243223C2 (ru) 2004-12-27
CA2399116A1 (en) 2001-08-09
PE20020747A1 (es) 2002-08-17
DK1251846T3 (da) 2004-11-29
DE60012988T2 (de) 2005-08-25
TWI245041B (en) 2005-12-11
NZ521136A (en) 2004-05-28
HK1047891B (en) 2005-01-28
EP1251846A1 (en) 2002-10-30
US6750246B1 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
TR200402454T4 (tr) C-4 karbonat taksanlar.
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
DE60144392D1 (de) Antivirale mittel
DE60330407D1 (de) Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
DE60324155D1 (de) Indol-3-carbinol metaboliten als chemotherapeutische und chemopräventive wirkstoffen
CO5590918A2 (es) Formulaciones
CY1107939T1 (el) Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
TR200402529T4 (tr) Yeni Fenalliloksi fenil türevleri.
DE60120427D1 (de) Radicicol und monocillin und ihre analogen und ihre anwendungen
DE602004031410D1 (de) Inden derivate als pharmazeutika
DE60005517D1 (de) Kaliumkanal-blockierende mittel
ATE284882T1 (de) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
BR0014687A (pt) Compostos de taxano pentacìclico
AR025380A1 (es) Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus.
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
DE60119514D1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure
BR0211762A (pt) Certos policetìdeos substituìdos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de tumores
EA200000261A3 (ru) Новые замещенные димерные соединения, способ их получения и содержащияся их фармацевтическая композиция
DE60213541D1 (de) Discodermolid-Analoga und ihre pharmazeutische Verwendung
ATE342906T1 (de) Tumorhemmende cerverbindungen
TH51266A (th) C-4 คาร์บอเนทแทกเซน